Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer

Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta and Heikki Joensuu
Journal of Nuclear Medicine December 1997, 38 (12) 1907-1911;
Heikki Minn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Lapela
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pekka J. Klemi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reidar Grénman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sirkku Leskinen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Lindholm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jörgen Bergman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esa Eronen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merja Haaparanta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heikki Joensuu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 12
December 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta, Heikki Joensuu
Journal of Nuclear Medicine Dec 1997, 38 (12) 1907-1911;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta, Heikki Joensuu
Journal of Nuclear Medicine Dec 1997, 38 (12) 1907-1911;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
  • Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
  • Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas
  • Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases
  • Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification
  • Prediction of Disease-Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging
  • Use of 18F-FDG PET for Primary Treatment Strategy in Patients with Squamous Cell Carcinoma of the Oropharynx
  • Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies
  • Prediction of Survival and Therapy Outcome with 11C-Tyrosine PET in Patients with Laryngeal Carcinoma
  • Nuclear medicine in imaging head and neck malignancies
  • Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy
  • Google Scholar

More in this TOC Section

  • Quantifying the Radiation Dosage to Individual Skeletal Lesions Treated with Samarium-153-EDTMP
  • Radiotoxicity After Strontium-89 Therapy for Bone Metastases Using the Micronucleus Assay
  • Lymphoscintigraphy and Radioguided Biopsy of the Sentinel Axillary Node in Breast Cancer
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire